Who invested in Terns Pharmaceuticals?
Terns Pharmaceuticals's investors include Vivo Capital, OrbiMed, Eli Lilly, Lilly Asia Ventures and Lily Asia, and 1 more on record.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$730Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From the SEC filings it signed: 4 on the team.
On the board, as filediCarl GordonDavid FellowsElise WangHongbo LuJeffrey KindlerJill QuigleyYi Shi
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Terns Pharmaceuticals's investors include Vivo Capital, OrbiMed, Eli Lilly, Lilly Asia Ventures and Lily Asia, and 1 more on record.
Terns Pharmaceuticals has raised $730M across 2 rounds since 2018.
Terns Pharmaceuticals's most recent round was an Undisclosed round of $650M in Dec 2025.
Its most recent round, $650M in Dec 2025, is also its largest on record.
Terns Pharmaceuticals's first round on record, in Oct 2018, was backed by Vivo Capital, Lily Asia and Orbimed/ Decheng.
Terns Pharmaceuticals's latest named round is an Undisclosed round, in Dec 2025.
Terns Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.